Cart
sales@molnova.com
Protionamide
CAS No. 14222-60-7
Protionamide( Tebeform )
Catalog No. M11772 CAS No. 14222-60-7
Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 41 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 63 | In Stock |
|
| 500MG | 81 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameProtionamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtionamide (or prothionamide) is a drug used in the treatment of tuberculosis.
-
DescriptionProtionamide (or prothionamide) is a drug used in the treatment of tuberculosis; has also been tested for use in the treatment of leprosy.
-
In Vitro——
-
In Vivo——
-
SynonymsTebeform
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number14222-60-7
-
Formula Weight180.27
-
Molecular FormulaC9H12N2S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 7 mg/mL (38.83 mM); DMSO: 36 mg/mL (199.7 mM)
-
SMILESCCCC1=NC=CC(=C1)C(N)=S
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Projahn M, et al. Antimicrob Agents ChemOthers. 2011 Sep;55(9):4408-1
molnova catalog
related products
-
N,N,O-Tridesmethylve...
N,N,O-Tridesmethylvenlafaxine is an endogenous metabolite.
-
Mogroside III-A2
Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
-
Moxnidazole
Moxnidazole, a 5-nitroimidazole, is mutagenic in microbial assays and in Drosophila, inducing genetic alterations in mouse somatic cells.
